Luis Alvarez

Founder at Elevian, Inc.

Finance

Health Technology

Technology Services

Profile

Luis Alvarez is the founder of Elevian, Inc. and Theradaptive, Inc. He has a graduate and doctorate degree from the Massachusetts Institute of Technology.

Luis Alvarez active positions

Companies	Position	Start
Elevian, Inc. Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA.	Founder	-
Theradaptive, Inc. Theradaptive, Inc. Packaged SoftwareTechnology Services Theradaptive, Inc. is a venture-backed biopharmaceutical company based in Lexington, MA. The company aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision. The company's clinical studies focus on the evaluation of amp2 coated rebossis for bone tissue regeneration. The company was founded by Luis Alvarez.	Chief Executive Officer	-

All active positions of Luis Alvarez

Training of Luis Alvarez

Massachusetts Institute of Technology

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Luis Alvarez's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Elevian, Inc. Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA.	Health Technology
Theradaptive, Inc. Theradaptive, Inc. Packaged SoftwareTechnology Services Theradaptive, Inc. is a venture-backed biopharmaceutical company based in Lexington, MA. The company aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision. The company's clinical studies focus on the evaluation of amp2 coated rebossis for bone tissue regeneration. The company was founded by Luis Alvarez.	Technology Services